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a b s t r a c t
Uranium workers are chronically exposed to low levels of radon decay products (RDP) and gamma (γ)
radiation. Risks of leukemia from acute and high doses of γ-radiation are well-characterized, but risks
from lower doses and dose-rates and from RDP exposures are controversial. Few studies have evaluated
risks of other hematologic cancers in uranium workers. The purpose of this study was to analyze
radiation-related risks of hematologic cancers in the cohort of Eldorado uranium miners and
processors ﬁrst employed in 1932–1980 in relation to cumulative RDP exposures and γ-ray doses.
The average cumulative RDP exposure was 100.2 working level months and the average cumulative
whole-body γ-radiation dose was 52.2 millisievert. We identiﬁed 101 deaths and 160 cases of
hematologic cancers in the cohort. Overall, male workers had lower mortality and cancer incidence
rates for all outcomes compared with the general Canadian male population, a likely healthy worker
effect. No statistically signiﬁcant association between RDP exposure or γ-ray doses, or a combination of
both, and mortality or incidence of any hematologic cancer was found. We observed consistent but
non-statistically signiﬁcant increases in risks of chronic lymphocytic leukemia (CLL) and Hodgkin
lymphoma (HL) incidence and non-Hodgkin lymphoma (NHL) mortality with increasing γ-ray doses.
These ﬁndings are consistent with recent studies of increased risks of CLL and NHL incidence after γ-
radiation exposure. Further research is necessary to understand risks of other hematologic cancers
from low-dose exposures to γ-radiation.
& 2014 The Authors. Published by Elsevier Inc.
1. Introduction
Signiﬁcantly increased risks of leukemia associated with expo-
sure to high acute doses of ionizing radiation are well-studied and
recognized (UNSCEAR, 2008). The evidence of radiation-associated
risks of other hematologic cancers, including Hodgkin lymphoma
(HL), multiple myeloma (MM) and non-Hodgkin lymphoma (NHL),
is mixed (Boice, 1992; Ron, 1998), with some studies showing signi-
ﬁcantly increased risks of NHL in some subgroups (Hsu et al., 2013;
Richardson et al., 2009), and little evidence of increased risks of MM
or HL. The risks of protracted low-dose radiation are also not clear.
Recent studies of nuclear workers occupationally exposed to low
doses of radiation showed increased radiation risks of leukemia, NHL
and MM, but little evidence of radiation-associated risks of HL or
chronic lymphocytic leukemia (CLL) (Cardis et al., 2007; Muirhead
et al., 2009; Vrijheid et al., 2008).
Ionizing radiation was thought to have little evidence of an
effect on CLL in the study of atomic bomb (A-bomb) survivors from
Hiroshima and Nagasaki, based mainly on the ﬁrst 40-years of
follow-up (Preston et al., 1994). However, CLL is very rare in the
Japanese population (6%) (Tamura et al., 2001), making risk
assessment difﬁcult (Richardson et al., 2005). Recent results of the
A-bomb survivors reported a signiﬁcant increased risk of CLL,
albeit based on 12 cases diagnosed over 55 years of follow-up (Hsu
et al., 2013). A signiﬁcantly increased radiation risk of CLL, similar
in size to risks of other types of leukemia, was also reported in a
recent study of Chornobyl cleanup workers exposed to protracted
low-dose external irradiation (Zablotska et al., 2013).
Once inhaled, radon decay products (RDP) can be distributed
to the red bone marrow and consequently may increase the risk
of leukemia (Laurier et al., 2001). Since uranium miners are also
exposed to gamma (γ) radiation doses, there is growing interest
in understanding the risks of leukemia and other hematologic
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cancers in these workers. Past mortality-based cohort and case-
control studies of uranium miners and processing workers
(Darby et al., 1995; Laurier et al., 2001; Polednak and Frome,
1981), as well as recent ecological studies (Boice et al., 2009,
2007, 2010), provide little evidence of an association between
radon and leukemia. However, recent studies based on cancer
incidence reported elevated risks of CLL and NHL (attributed to
radon, RDP, and γ-rays) (Mohner et al., 2006, 2010; Rericha et al.,
2006).
The updated Eldorado cohort consists of 17,660 uraniummine, mill
and processing workers, ﬁrst employed in 1932–1980, with relatively
recent mortality (1950–1999) and cancer incidence (1969–1999)
follow-up (Lane et al., 2010). The purpose of the current analysis is
to assess the radiation risks (RDP exposures and γ-ray doses) of
hematologic cancers (combined), malignant lymphoma (HL and NHL),
leukemia (CLL and non-CLL) and MM among Eldorado workers.
2. Materials and methods
A detailed description of the Eldorado cohort, record linkages, outcomes and
exposures has been published previously (Lane et al., 2010).
2.1. Cohort
The cohort included uranium mine and mill workers employed at two mine
sites (Port Radium, Northwest Territories, and Beaverlodge, northern Saskatch-
ewan), and workers employed at the radium and uranium reﬁning and proces-
sing plant (Port Hope, Ontario), with a small number of individuals employed at
“other sites” including head ofﬁce, aviation, research and development, and
exploration (N¼19,855). The sub-cohort membership was based on the employ-
ment site where a worker spent the longest period of time working for Eldorado.
Cohort members were ﬁrst employed between 1932 and 1980, were between
the ages of 15 and 75 years, and alive at start of follow-up in 1950 (mortality
analysis) or 1969 (cancer incidence analysis).
2.2. Record linkage
An internal linkage and data processing led to the exclusion of 2195 (11.0%)
records with missing information (i.e., sex, birth year, age out of range, no
occupational record, and no exposure data). The ﬁnal cohort for mortality
analysis included 17,660 subjects (88.9% of the original cohort). Information
on “fact of death” was used for “death clearance” between 1950 and 1969
(n¼886) and 4 additional subjects were excluded because their RDP exposure
occurred after cancer diagnosis. The incidence analysis is therefore based on
16,770 subjects.
The cohort was linked to the Historic Summary Tax File (HSTF), the Canadian
Mortality Database (CMDB) and the Canadian Cancer Database (CCDB) to ascertain
mortality and cancer incidence until the end of 1999. In total, the vital status of
15,580 (78.5%) cohort subjects was ascertained. Individuals (N¼4307, 21.8%) who
could not be linked to the HSTF or the CMDB had their termination date at work as
the last date known alive.
The HSTF includes identiﬁers and the minimal amount of data required to
ascertain the vital status and location of individuals since 1984. The HSTF was used
to enhance the Eldorado cohort linkage by ﬁlling in data gaps, to determine the
vital status of the cohort members at the end of the follow-up period, and to
evaluate the results of the mortality linkage. The CMDB (1950 to present) is based
on the vital statistics program at Statistics Canada, that routinely collects demo-
graphic and cause of death information from all provincial and territorial vital
statistics registries on all deaths in Canada. Some data are also collected on
Canadian residents who died in some states of the United States of America.
Registration of deaths is a legal requirement through the Vital Statistics Acts (or
equivalent legislation) in each Canadian province and territory, so reporting is
virtually complete. Under-coverage is thought to be minimal (1% or less) (Goldberg
et al., 1993). Cancer incidence records from provincial and territorial cancer
registries are sent to Statistics Canada where they are edited, standardized and
transformed into a format suitable for record linkage, thereby creating the CCDB
(1969 to present). Cancer reporting is virtually complete and of high quality, since it
is routinely checked for accuracy through regular assessments by Statistics Canada
and the cancer registries. The cancer data are also linked with mortality data to
ensure the completeness and correctness of vital status information and to capture
missed cancer cases. Both linking procedures optimize the accuracy of the data
(Canadian Cancer Society, 2013).
2.3. Outcomes
For the mortality and cancer incidence analyses, the underlying causes of death
and cancer diagnoses were recoded from the original International Classiﬁcation of
Disease (ICD) code in use at the time of death or diagnosis to the International
Classiﬁcation of Diseases, Ninth Revision (ICD-9) (WHO, 1998) or the International
Classiﬁcation of Diseases for Oncology: Morphology of Neoplasms, Third Edition
(ICD-O-3) (Fritz et al., 2000). This included all hematologic cancers combined
(ICD-9: 200.0–208.9) and all malignant lymphoma (ICD-9: 200.0–202.9), Hodgkin
lymphoma (HL, ICD-9: 201.0–201.9), non-Hodgkin lymphoma (NHL, ICD-9: 200.0–
200.9 & 202.0–202.9), multiple myeloma (MM, ICD-9: 203.0–203.9), all leukemia
(ICD-9: 204.0–208.9), CLL (ICD-9: 204.1, ICD-O-3: M9823/3) and non-CLL, which
were evaluated separately.
2.4. Exposures
The detailed work history ﬁle was obtained from Eldorado company records.
A detailed description of how RDP exposure was estimated is available (Howe et al.,
1986, 1987; Lane et al., 2010). In brief, the annual mean RDP exposure in WLM1 was
calculated by summing over the WL measurements available for each type of
workplace, the proportion of workers in each occupation and the proportion of
time spent in each type of workplace by workers in each occupation. Workplace
RDP concentration measurements were supplemented by data on seasonal mine
ventilation rates, building air volumes and air exchange rates. Other studies of
uranium miners used similar methods to assign personal exposures based on the
job-exposure matrix (NRC, 1999). Exposures for workers with additional mining
experience in early non-Eldorado Western Canadian mines were estimated based
on the Beaverlodge WL data. Any additional RDP exposures (i.e., from Ontario
uranium mines) were obtained from the National Dose Registry (NDR2). The
current study also has information on individual γ-ray doses for all cohort subjects.
Personal γ-ray doses were calculated from the average dose-rates and time on the
job and expressed in millisieverts (mSv) for workers who did not wear a personal
dosimeter.
2.5. Statistical analysis
Each individual contributed person-years at risk from the later of the date of
hire or the start date of follow-up, to the exit date. ‘Start date’ was deﬁned as
January 1st, 1950, for the mortality analysis and January 1st, 1969, for the incidence
analysis. ‘Exit date’ was deﬁned as December 31st, 1999, the date of cancer
diagnosis or death, or the last date known alive (deﬁned as date of last employment
or contact), whichever occurred earlier.
The initial set of analyses was based on external comparisons of the cohort
with the general Canadian population. Observed (O) and expected (E) values were
used to estimate standardized mortality ratios (SMR) and standardized incidence
ratios (SIR) by means of indirect standardization. Expected values were derived
from Canadian population mortality (1950–1999) and cancer incidence (1969–
1999) rates, adjusted for sex, age and calendar year at risk. Incidence and mortality
for leukemia subtypes were not available for the general Canadian population, so
SMRs and SIRs were provided for all leukemia combined.
The second set of analyses was based on internal comparisons of the cohort and
used grouped Poisson regression (Breslow and Day, 1987; Preston et al., 1993) to
estimate risks using a simple linear relative risk (RR) model:
Relative risk¼ 1:0þðβ XÞexpðΣ iγiziÞ ð1Þ
where X represents factors such as RDP exposure or γ-ray dose, zi are potential
modifying factors such as age at ﬁrst γ-ray dose, and β and γi are coefﬁcients,
estimated using maximum likelihood techniques. The beta coefﬁcient (β) is
referred to as the excess relative risk (ERR) per unit of exposure; by adding 1.0 to
the ERR one obtains the relative risk (RR) per 100 WLM for RDP exposure and RR
per one sievert (Sv) for γ-ray dose. The summary person-years at risk were cross-
classiﬁed by age at risk (15–19, 20–24… 85–100 years), calendar year at risk3
1 The concentration of RDP in workplace air was expressed in Working Levels
(WL), where 1 WL is the concentration of RDP per liter of air that would result in
the ultimate release of 1.3105 MeV of potential alpha energy. Occupational
exposure to RDP is the product of time in the workplace and the concentration
of RDP in the workplace air, measured in Working Level Months (WLM), where
1 WLM is equivalent to one working month (170 h) in a concentration of 1 WL.
2 The NDR had no early records from Eldorado or other early Western Canadian
mines. For all other non-Eldorado radiation exposures, the cohort was linked to the
NDR. Miners’ γ-ray doses only became available in the NDR from 1981 onward.
Miners were not included in the IARC15 country study of nuclear workers (Cardis
et al., 2007); there is no evidence of a problem in the transfer of mining company
records to the NDR.
3 Calendar year at risk for the cancer incidence analysis was (1969–1974,…
1995–1999).
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(1950–54, 1955–59… 1995–1999), employment site (Port Hope, Port Radium,
Beaverlodge, “other sites”), total duration of employment (o6 months,
6 monthsþ)4, age at ﬁrst exposure, cumulative exposure, and years since ﬁrst
exposure. This was done separately for RDP exposures and γ-ray doses. In contrast
to Lane et al. (2010), both RDP exposures and γ-ray doses were lagged by 5 years to
account for the latency period between exposure and cancer incidence and
mortality. Finally, an exploratory analysis was performed for both RDP exposures
and γ-ray doses, lagged by 10 years, to compare our ﬁndings with a previously
published study (Richardson et al., 2009). The person-year weighted mean RDP
exposures and γ-ray doses in each cross-classiﬁed cell were used in the regression
analysis. We also estimated relative risks (RR) for γ-ray dose categories and
evaluated linear trend tests based on mean doses for dose categories (0–14, 15–
49 and 50–3420 mSv).
Regression parameters, 95% conﬁdence intervals (95% CI) and p-values were
estimated using the maximum likelihood method in the AMFIT module of the
EPICURE software (Preston et al., 1993). Tests of statistical signiﬁcance were based
on the likelihood ratio test and all p-values were two-sided. Because of the form of
Eq. (1), the possible values of β were limited by the requirement that the
corresponding relative risks were not negative. If the likelihood of a point or
bound estimate did not converge, the minimum value for β was given by o0.
The number of cancer cases in this paper may differ between the external and
internal analyses. In the external analysis, the population incidence rates, used to
calculate expected cases, are based on newly diagnosed cancer cases. Thus, an
individual can contribute more than one cancer case to the rates. In the internal
analysis, the earliest diagnosed case is used so an individual can only contribute
one cancer case to the analysis.
3. Results
Thirty percent of Eldorado workers (O¼5332, N¼17,660) died
from 1950 to 1999 and 23% (O¼2210, N¼16,770) developed
cancer from 1969 to 1999. Table 1 presents the basic character-
istics of the cohort. Most workers were male (N¼16,236, 91.9% of
the cohort), so all further analyses were restricted to “all male
workers.” The mean RDP exposures and γ-ray doses (weighted by
person-years) are presented in Table 1 separately for the mortality
and incidence analyses. Mean RDP and γ-ray doses were higher in
the mortality analysis cohort, probably because workers with the
higher exposures (i.e., Port Radium workers in the 1930s and
1940s) died prior to 1969. Women had lower RDP exposures than
men, although γ-ray doses were comparable. Port Hope workers
had the highest γ-ray doses; 2-fold and 4-fold higher than
Port Radium and Beaverlodge workers, respectively.
Table 2 shows that the SMRs for HL, NHL, MM, and all leukemia
were lower than the Canadian general population; however, the
SMR was only statistically signiﬁcant for all leukemia (SMR¼0.69,
95% CI: 0.48, 0.97, p-value¼0.031). Similar results were observed
for the SIR analysis, but all leukemia (SIR¼0.79, 95% CI: 0.59, 1.03,
p-value¼0.088) was no longer statistically signiﬁcant. Only the SIR
for MM approached statistical signiﬁcance (SIR¼0.65, 95% CI: 0.40,
1.01, p-value¼0.055).
Age at risk, calendar year at risk, employment site and total
duration of employment signiﬁcantly affected risk estimates so all
subsequent analyses were controlled for these variables using
stratiﬁcation.
There were 101 deaths from hematologic cancers (7 HD, 42
NHL, 18 MM, and 34 all leukemia, Table 3) and 553,492 person-
years at risk in the male Eldorado mortality cohort. During 1969–
1999 incidence follow-up of this cohort, 160 cases of hematologic
cancers were diagnosed (10 HD, 78 NHL, 20 MM, and 52 all
leukemia, Table 3) and 373,477 person-years accumulated. Table 3
shows no relationship between RDP exposure and mortality or
cancer incidence for any of the hematologic cancers (Table 3). HL
incidence was borderline signiﬁcant (N¼10, ERR/100 WLM¼20.7,
95% CI: o0, 324, p¼0.081); however, this was based on few cases
and a very wide conﬁdence interval. In the γ-ray dose analysis,
a statistically non-signiﬁcant excess risk was also found for HL
incidence (N¼10, ERR/Sv¼13.0, 95% CI: o0, 139, p-value¼0.504)
and CLL incidence (N¼22, ERR/Sv¼7.52, 95% CI: o0, 57.1,
p-value¼0.375) and NHL mortality (N¼42, ERR/Sv¼3.54, 95%
CI: o0, 29.5, p-value¼0.593). In the categorical analysis, risks of
HL and CLL incidence increased with γ-ray dose, but linear trend
tests were not statistically signiﬁcant (p for linear trend¼0.672
and 0.271, respectively, not shown).
Table 4 shows that HL incidence was signiﬁcantly associated
with γ-ray dose among Beaverlodge workers, but the ﬁnding
was based on few cases (N¼7, ERR/Sv¼91.3, 95% CI: o0, 415,
p-value¼0.145). A high, although not statistically signiﬁcant
Table 1
Basic characteristics of the Eldorado uranium workers cohort.
Characteristic Mortality cohort
(1950–1999)
Incidence cohort
(1969–1999)
Number of subjects total 17,660 16,770
Men (%) 16,236 (91.9) 15,366 (91.6)
Beaverlodge 9,498 9,231
Port Radium 3,047 2,687
Port Hope 2,652 2,416
Other sites 1,039 1,032
Women (%) 1,424 (8.1) 1,404 (8.4)
Meana RDP exposure,
WLM (SD, range)
Men 100.2 (254.4, 0–2,569.0) 88.6 (229.1, 0–2,663.0)
Beaverlodge 84.8 (203.4, 0–2,441.0) 60.9 (143.5, 0–1,617.0)
Port Radium 180.1 (349.5, 0–2,569.0) 199.2 (362.0, 0–2,663.0)
Port Hope 14.2 (54.1, 0–626.0) 10.4 (43.0, 0–590.3)
Other sites 14.9 (85.8, 0–984.2) 7.9 (56.2, 0–984.2)
Women 4.6 (10.1, 0–67.6) 3.5 (9.0, 0–67.6)
Meanb γ-ray dose,
mSv (SD, range)
Men 52.2 (152.4, 0–3,420.0) 41.5 (116.4, 0–2,921.0)
Beaverlodge 25.6 (39.4, 0–393.1) 25.2 (39.5, 0–393.1)
Port Radium 46.8 (82.2, 0–897.3) 43.7 (84.4, 0–1,076.0)
Port Hope 121.5 (306.8, 0–3,420.0) 101.7 (257.0, 0–2,921.0)
Other sites 23.4 (42.3, 0–250.7) 18.5 (37.0, 0–250.7)
Women 34.4 (77.4, 0–619.8) 24.9 (66.6, 0–619.8)
Abbreviations: mSv, millisieverts; RDP, radon decay product; SD, standard devia-
tion; WLM, working level months.
a Weighted by person-years and lagged by 5 years.
b Weighted by person-years and lagged by 5 years.
Table 2
SMRs and SIRs and 95% CIs for various cancers and causes of death compared to
Canadian national incidence (1969–1999) and mortality (1950–1999) rates
for males.
Cause of death Cancer mortality
Observed Expected SMRa and 95% CI p-Value
Hodgkin lymphoma 7 9.24 0.76 (0.30, 1.56) 0.594
Non-Hodgkin lymphoma 42 46.28 0.91 (0.65, 1.23) 0.59
Multiple myeloma 18 22.12 0.81 (0.48, 1.29) 0.45
All leukemia 34 49 0.69 (0.48, 0.97) 0.031
Cancer site Cancer incidence
Observedb Expected SIRa and 95% CI p-Value
Hodgkin lymphoma 14 14.98 0.93 (0.51, 1.57) 0.935
Non-Hodgkin lymphoma 80 90.09 0.89 (0.70, 1.11) 0.312
Multiple myeloma 20 30.67 0.65 (0.40, 1.01) 0.055
All Leukemia 53 67.13 0.79 (0.59, 1.03) 0.088
Abbreviations: CI, conﬁdence interval; SIR, standardized incidence ratio; SMR,
standardized mortality ratio.
a Adjusted for age and calendar year at risk by stratiﬁcation.
b The number of observed cases reﬂects the incidence of newly diagnosed
cancer cases where a single individual can contribute more than one case of cancer.
4 Total duration of employment was split at 6 months, as risk drops after
6 months but then remains constant, as previously observed (Howe et al., 1988).
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increased risk of HL incidence related to RDP exposures was also
observed among workers from this mine site. A moderate correla-
tion between RDP exposures and γ-ray dose (Pearson0s r¼0.45)
was observed among Beaverlodge workers, so the effects of both
exposures were examined in one model. The entire increase in risk
of HL was primarily due to γ-ray dose since the addition of the
RDP exposure term to the model did not signiﬁcantly improve the
model ﬁt (p40.50, not shown).
The risk of NHL incidence related to γ-ray dose was statistically
non-signiﬁcantly increased among Port Radiumworkers (N¼21, ERR/
Sv¼2.19, 95% CI: o0, 27.6, p-value 40.50). Risks increased with
γ-ray dose: 15–49 mSv (RR¼1.35, 95% CI: 0.46, 3.98) and Z50 mSv
Table 3
ERRs for various causes of death and cancer in relation to RDP exposures and γ-ray doses.
RDP exposures γ-Ray doses
Cause of death Mortality
Number of deaths ERR/100 WLM (95% CI)a p-Valueb ERR/Sv (95% CI)c p-Valueb
All malignant lymphoma 49 0 (n.e.) 0.9 0.29 (n.e.) 0.825
Hodgkin lymphoma 7 0.2 (o0, 5.79) 0.576 0.29 (n.e.) 0.752
Non-Hodgkin lymphoma 42 0.03 (n.e.) 0.768 3.54 (o0, 29.5)d 0.593
Multiple myeloma 18 0.04 (o0, 1.07) 0.845 0.29 (n.e.) 0.639
All Leukemia 34 0.02 (o0, 0.46) 0.808 0.29 (n.e.) 0.824
All hematological cancers 101 0.02 (o0, 0.23) 0.799 0.29 (n.e.) 0.572
Cancer site Cancer incidence
Number of cases ERR/100 WLM (95% CI)a p-Valueb ERR/Sv (95% CI)c p-Valueb
All malignant lymphoma 88 0.06 (o0, 0.52) 0.568 0.34 (n.e.) 0.764
Hodgkin lymphoma 10 20.7 (o0, 324) 0.081 13.0 (o0, 139)d 0.504
Non-Hodgkin lymphoma 78 0.04 (o0, 0.46) 0.676 0.34 (n.e.) 0.715
Multiple myeloma 20 0.01 (o0, 0.66) 0.935 0.34 (n.e.) 0.593
CLL 22 0.04 (n.e.) 0.59 7.52 (o0, 57.1) 0.375
Leukemia, excluding CLL 30 0.04 (n.e.) 0.489 0.34 (n.e.) 0.739
All hematological cancers 160 0.01 (o0, 0.17) 0.823 0.34 (n.e.) 0.536
Abbreviations: CLL, chronic lymphocytic leukemia; ERR, excess relative risk; n.e., not estimated; RDP, radon decay products; Sv, sievert; WLM, working level months.
a Model adjusted for employment site, age at risk, calendar year at risk and duration of employment by stratiﬁcation. The γ-ray doses were not included in the model.
b p-Values from the likelihood ratio test comparing nested model with and without the continuous exposure term.
c Model adjusted for employment site, age at risk, calendar year at risk and duration of employment by stratiﬁcation. RDP exposures were not included in the model.
d ERR estimate increased appreciably (Z10%), but remained not statistically signiﬁcant in the analyses with lag times 10 years; all other estimates remained unchanged.
Table 4
Associations between RDP exposures and γ-ray doses and incidence of HL, NHL and CLL (1969–1999) by site.
Characteristic Site
Beaverlodge Port radium Port hope Other sites
Correlation between WLM and γ-ray dose 0.45 0.24 0.93 0.05
Hodgkin lymphoma
Number of cases 7 2 0 1
γ-Ray doses
ERR/Sv (95% CI) 91.3 (o0, 415) n.e. n.e. n.e.
p-Valuea 0.145
RDP exposures
ERR/100 WLM (95% CI) 23.2 (o0, 365) n.e. n.e. n.e.
p-Value 0.19
Non-Hodgkin lymphoma
Number of cases 37 21 15 5
γ-Ray doses
ERR/Sv (95% CI) 2.54 (n.e.) 2.19 (o0, 27.6) 0.34 (n.e.) n.e.
p-Value 0.388 40.50 40.50
RDP exposures
ERR/100 WLM (95% CI) 0.062 (n.e.) 0.14 (o0, 0.99) 0.17 (n.e.) n.e.
p-Value 40.50 0.372 40.50
CLL
Number of cases 15 3 4 0
γ-Ray doses
ERR/Sv (95% CI) 11.8 (o0, 84.3) 10.2 (o0, 731) 0.34 (n.e.) n.e.
p-Value 0.268 40.50 40.50
RDP exposures
ERR/100 WLM (95% CI) 0.17 (o0, 1.89) 0.04 (n.e.) 0.17 (n.e.) n.e.
p-Value 40.50 40.50 40.50
Abbreviations: CLL, chronic lymphocytic leukemia; ERR, excess relative risk; n.e., not estimated; RDP, radon decay products; SD, standard deviation; Sv, sievert; WLM,
working level months.
a p-Values from the likelihood ratio test comparing nested model with and without the continuous exposure term.
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(RR¼1.53, 95% CI: 0.47, 5.00) compared to o15mSv (p for linear
trend¼0.537, not shown). The addition of the RDP exposure term to
the model did not signiﬁcantly improve the model ﬁt (p40.50, not
shown).
The risk of CLL incidence related to γ-ray dose was statistically
non-signiﬁcantly increased among Beaverlodge workers (N¼15,
ERR/Sv¼11.8, 95% CI: o0, 84.3, p-value¼0.268) and Port Radium
workers (N¼3, ERR/Sv¼10.2, 95% CI: o0, 731, p-value 40.50).
Again, risks increased with γ-ray dose and the addition of the RDP
exposure terms to the models did not improve the models’ ﬁt
(both p-values 40.50, not shown). For Beaverlodge and Port
Radium workers, risks increased with increasing γ-ray doses, but
the risks for Port Hope workers, who had the highest γ-ray doses,
were negative. Radiation-related risks of CLL did not differ across
facilities (p heterogeneity across facilities 40.50, not shown).
Three of the NHL cases in our study were small cell lymphomas
(ICD-O-3: M9670.3), a type of B-cell lymphoma of which CLL is
considered one of the stages (Harris et al., 1999). When these were
analyzed together with CLL cases, the combined estimate was ERR/
Sv¼4.91, 95% CI: o0, 41.2, p¼0.497. The risk among Beaverlodge
and Port Radium workers was ERR/Sv¼7.69, 95% CI: o0, 57.5,
p¼0.387 and ERR/Sv¼8.74, 95% CI: o0, 657, p40.50, respectively
(not shown).
4. Discussion
This report presents the analysis of 50 years of mortality (1950–
1999) and 31 years of cancer incidence (1969–1999) in a cohort of
Eldorado uranium workers known to have worked sometime
between 1932 and 1980 and followed-up until the end of 1999.
Overall, workers had lower rates of mortality and cancer
incidence of hematologic cancers compared to the age- and
calendar year at risk adjusted rates for the general Canadian male
population, a likely healthy worker effect (Howe et al., 1988). No
statistically signiﬁcant relationship was observed between RDP
exposures or γ-ray doses, or a combination of both, and mortality
or incidence of any hematologic cancers. However, for γ-ray doses,
there was suggestive, though statistically non-signiﬁcant, evidence
of increased risk of CLL and HL incidence and NHL mortality with
increasing dose.
One of the main strengths of this study is its long-term follow-up
using very high quality cancer incidence and mortality population-
based databases (Canadian Cancer Society, 2013; Goldberg et al.,
1993). Comparatively high rates of follow-up were achieved through
substantial improvements to the completeness to the nominal roll
and work history ﬁles, multiple internal linkages to eliminate
duplicate records, linkages to the HSTF, CMDB, CCDB, and the manual
resolution of potential computer links.
The follow-up of the entire cohort in terms of both incidence
and mortality is unique and provided a complimentary view of the
effects of RDP exposures and γ-ray doses on the risk of hemato-
logic cancers. The total number of hematologic cancer cases
(n¼160) was signiﬁcantly larger than the number of deaths
(n¼101), even though incidence follow-up was 19 years shorter
than mortality follow-up. This is most likely because people
diagnosed with HL, NHL and CLL, the most indolent of hematologic
cancers, often do not die from these conditions (Canadian Cancer
Society, 2013); thus workers with these conditions will often not
have them recorded as the underlying cause of death on death
certiﬁcates. If any advances in treatment occur during the study
period, mortality would become a less sensitive outcome, whereas
incidence would be unaffected. Likewise, cancers with high
survival rates, such as HL, NHL and CLL, would not be detected
by mortality statistics.
Hematologic cancers, in particular leukemia, are among the
most radiosensitive cancers (NRC, 2006). They originate in the
mutated cells of the bone marrow and from the mutated cells of
the immune system. Whole-body γ-ray doses have been found to
signiﬁcantly increase risks of leukemia in A-bomb survivors from
Japan (Hsu et al., 2013), risks of leukemia, NHL and MM in the U.K.
radiation workers (Muirhead et al., 2009), and risks of leukemia
and NHL in Chornobyl cleanup workers (Kesminiene et al., 2008;
Zablotska et al., 2013). Less is known about the effects of radon
decay alpha particles on the bone marrow, but a recent study
(Harley and Robbins, 2009) reported that the bronchial mucosa
has an abundance of circulating lymphocytes, thus suggesting that
RDP exposures could be associated with hematologic cancers
originating from these cells.
Several limitations should be considered when interpreting the
above results. First, the radiation exposure and corresponding
doses to red bone marrow in uranium workers come from
exposures to radon gas, RDP and long-lived radionuclides present
in the uranium ore dust and to external gamma radiation (Marsh
et al., 2012). Similar to other studies (NRC, 1999), the current
analysis only evaluated RDP exposures, which were calculated as
whole-body doses, while bone marrow doses would be a more
relevant measure (NRC, 2006). The impact of this is to possibly
underestimate radiation risks.
Another important limitation is the study0s limited statistical
power due to the low RDP exposures and γ-ray doses, and the
rareness of hematologic cancers. This could be addressed through
further follow-up and pooling of this cohort with other cohorts of
uranium workers.
Effects of other carcinogens in ore require careful consideration.
Beaverlodge ore was relatively clean with minimal amounts of
other carcinogens, but Port Radium ore contained arsenic and
cobalt. Arsenic, a known human carcinogen (IARC, 1980), was
recently shown to increase lung cancer among uranium miners
(Taeger et al., 2009); however, no such relationship was reported
for lymphoma, MM or leukemia. It is unlikely that the suggested
increased risk of CLL reported here is confounded by these
carcinogens. In addition to ore, Port Hope workers were exposed
to processing chemicals (i.e., ammonia, ﬂuoride) and a variety of
uranium compounds at higher concentration and of greater
solubility (i.e., UO3, UF6) than that found in the ore. Port Hope
workers were also exposed to radium compounds, uranium metal
and some enriched uranium, which were recently shown to
increase the risks of hematologic cancers (Guseva Canu et al.,
2011). However, Port Hope workers provided no evidence of
elevated risk of hematologic cancers.
A recent comprehensive report (Preston et al., 2013) evalu-
ated radiation exposure assessment errors and their impact on
health risks associated with exposure to ionizing radiation and
listed numerous sources of uncertainty associated with expo-
sure to radon-decay products. One of the main sources of
exposure errors would be shared dose errors, common to all
individuals within a group, as well as unshared errors, unique to
an individual within a cohort. Most RDP exposure measurement
errors in the current study are likely to be non-differential. As
pointed out by Blair et al. (2007), misclassiﬁcation of exposure
in studies of the association between airborne measurements of
radon gas and cancer in underground miners is unlikely and the
estimates of relative risk are generally unbiased. Measurement
errors in exposure estimation almost certainly decreased with
calendar time; thus, the Port Radium cohort had greater mea-
surement errors than the Beaverlodge cohort, and recent work-
ers had lower mean errors than earlier workers. The impact of
such measurement errors depends on a number of factors, in
particular, the quantitative nature of the error and the risk
function considered. Further studies are necessary to better
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understand the effects of uncertainties in dose estimation on
risk estimates.
A further consideration is that residential radon exposure likely
had a greater relative contribution to total RDP exposure in recent
times when occupational exposures were lower. It is known that
many houses in Uranium City, Port Hope, and the Eldorado town
site required remedial work for reduction of radon concentrations.
It is likely Eldorado workers lived in these communities at some
point; however, information is not available to assign individual
residential radon exposures to workers, so it is not possible to
estimate residential radon risks. However, if there is no relation-
ship between residential radon and total occupational RDP expo-
sure, the risk estimates would be unbiased. In general, random
misclassiﬁcation of residential radon exposure would bias relative
risk estimates towards the null.
Tobacco smoking is a recognized risk factor for some leukemia
subtypes (Musselman et al., 2013), but the evidence for association
of smoking with NHL (Gibson et al., 2013) and multiple myeloma
(Psaltopoulou et al., 2013) is less consistent. For smoking to modify
RDP- or gamma-related risks of hematologic cancers it should also
be correlated with RDP exposure and γ-ray doses. A case-control
study of the Beaverlodge miners (L’Abbe et al., 1991), which
accounted for close to 60% of uranium miners in the Eldorado
cohort, provided no evidence that RDP exposure was correlated
with cigarette smoking among miners. Even though smoking was
banned at the Port Hope facility in the 1940s and 1950s and was
allowed on a very limited basis thereafter, and was banned in the
workplace at Beaverlodge in 1975, people still smoked outside the
workplace. Although smoking data were not available, our pre-
vious analysis of smoking-related cancers other than lung cancer
in the Eldorado cohort (Lane et al., 2010) showed that generally
they were not elevated, suggesting that smoking was not sub-
stantially elevated relative to the general Canadian male popula-
tion. Recent nested case-control studies of German (Schnelzer
et al., 2010), French (Leuraud et al., 2007) and Czech (Tomasek,
2011) uranium miners, as well as the pooled analysis of these
cohorts (Leuraud et al., 2011), showed that the RDP-associated
risks of lung cancer persist even after adjustment for smoking.
Similarly, smoking did not modify the γ-ray associated risks of
cardiovascular outcomes in the Japanese A-bomb survivors
(Shimizu et al., 2010) or workers of the Mayak Production
Association in the Southern Urals region of the Russian Federation
(Azizova et al., 2010).
This cohort presented a unique opportunity to investigate the
effects of RDP exposures and γ-ray doses in the same subjects. In our
cohort, RDP exposures and γ-ray doses generally were not correlated
(Pearson0s r¼0.17) except for the Port Hope site, where they were
strongly correlated (Pearson0s r¼0.93). Comparatively high γ-ray
doses can increase the risk of several cancer sites (UNSCEAR, 2008),
with leukemia being particularly sensitive. However, in the present
context, the mean γ-ray dose was fairly low (mean γ-ray
dose¼52.2 mSv for men), so it is certainly possible that the study
had low statistical power to detect any effect.
Risks of CLL recently received attention after two incidence-
based studies of occupationally exposed uranium workers sug-
gested that the increased risk of CLL may be due to γ-ray doses
rather than RDP exposures. One study (Rericha et al., 2006)
reported a signiﬁcant increase in CLL among Czech uranium
miners (RR¼1.96, 95%CI: 1.12, 3.42, p¼0.02 comparing the 80th
percentile of exposure (20 mGy) to the 20th percentile of exposure
(1 mGy)). The other study (Mohner et al., 2006) reported an
elevated risk of CLL in East German Uranium Miners only when
γ-radiation dose was examined alone.
The current study also did not observe an increase in CLL risk
with RDP exposures, but found a statistically non-signiﬁcant
increase in risk for γ-ray doses (ERR¼7.52 per Sv, 95% CI: o0,
57.1, p¼0.375). Relative risks increased with increasing dose, but a
linear trend test was not signiﬁcant (15–49 mSv (RR¼1.97, 95% CI:
0.65, 5.99) and Z50 mSv (RR¼2.25, 95% CI: 0.66, 7.64) compared
to o15 mSv, p for linear trend¼0.271). Furthermore, radiation
risks of CLL were increased both in Beaverlodge and Port Radium
workers (although based on few cases and with wide conﬁdence
intervals) and there was no heterogeneity in risks across all
facilities (p40.50).
The larger magnitude of radiation risks of CLL in our analysis
compared to other studies may reﬂect the greater γ-ray doses
observed in our cohort compared to other cohorts of uranium
miners. While a recent pooled analysis of nuclear power industry
workers from 15 countries found little evidence for an association
between low doses of external ionizing radiation, primarily γ-ray
dose, and CLL mortality (Vrijheid et al., 2008), recent studies of
incident CLL among Chornobyl cleanup workers reported
increased risks in relation to bone marrow doses of γ-radiation
(Kesminiene et al., 2008; Romanenko et al., 2008). Twenty-year
follow up of Chornobyl cleanup workers from Ukraine provided
evidence of signiﬁcantly increased risks of CLL due to protracted
gamma radiation exposures (ERR/Gy¼2.93, 95% CI: 0.07, 9.64,
p¼0.041) (Zablotska et al., 2013), as did a ﬁfty-ﬁve year follow up
of the A-bomb survivors (Hsu et al., 2013).
Richardson et al. (2009) reported elevated risk of NHL mortality
associated with whole-body radiation dose in both a cohort of
male nuclear workers and in the A-bomb survivors with γ-ray
doses lagged by 5 and 10 years. We observed statistically non-
signiﬁcantly increased radiation risks of NHL with γ-ray doses
lagged by 5 years. Similar results were observed when we
repeated our analyses using a 10-year lag (not shown). The results
for radiation risks of NHL incidence were inconsistent across
employment sites (negative for Beaverlodge workers; increased
for Port Radium workers).
Finally, MM incidence and mortality were not related to RDP
exposures or γ-ray doses under various lag assumptions, consistent
with a prior study of Czech uranium miners (Rericha et al., 2006).
5. Conclusions
Overall, workers had lower rates of mortality and cancer inci-
dence of hematologic cancers compared to the general Canadian
male population. No statistically signiﬁcant relationship was
observed between RDP exposures or γ-ray doses, or a combination
of both, and mortality or cancer incidence of hematologic cancers.
However, there was suggestive, though statistically non-signiﬁcant,
evidence of an increased risk of CLL and HL incidence, and NHL
mortality with increasing γ-ray dose. Further follow-up of hemato-
logic cancer incidence may shed more light on the risks from low-
dose γ-radiation. Pooling of the data from this and other uranium
worker cohorts will improve the statistical power of future analyses.
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